[{"address1": "#140, 14315 \u2013 118 Avenue", "city": "Edmonton", "state": "AB", "zip": "T5L 4S6", "country": "Canada", "phone": "250 744 2487", "fax": "250 708 4345", "website": "https://www.auriniapharma.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Aurinia Pharmaceuticals Inc. is a biopharmaceutical company that engages in delivering therapies to people living with autoimmune diseases with high unmet medical needs. It offers LUPKYNIS (voclosporin), an oral therapy for the treatment of adult patients with active lupus nephritis. The company also develops AUR200, a dual inhibitor of B cell activating factor and a proliferation inducing ligand for the potential treatment of autoimmune diseases. It has a collaboration and license agreement with Otsuka Pharmaceutical Co., Ltd. The company was incorporated in 1993 and is headquartered in Edmonton, Canada.", "fullTimeEmployees": 130, "companyOfficers": [{"maxAge": 1, "name": "Mr. Peter S. Greenleaf M.B.A.", "age": 54, "title": "President, CEO & Director", "yearBorn": 1970, "fiscalYear": 2024, "totalPay": 1591980, "exercisedValue": 0, "unexercisedValue": 4320000}, {"maxAge": 1, "name": "Mr. Joseph M. Miller CPA", "age": 50, "title": "Chief Financial Officer", "yearBorn": 1974, "fiscalYear": 2024, "totalPay": 866870, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Matthew Maxwell Donley M.B.A.", "age": 55, "title": "Chief Operations Officer", "yearBorn": 1969, "fiscalYear": 2024, "totalPay": 933951, "exercisedValue": 0, "unexercisedValue": 770000}, {"maxAge": 1, "name": "Mr. Stephen P. Robertson", "age": 42, "title": "Executive VP, General Counsel, Corporate Secretary & Chief Compliance Officer", "yearBorn": 1982, "fiscalYear": 2024, "totalPay": 799518, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Gregory F. Keenan M.D.", "age": 63, "title": "Chief Medical Officer", "yearBorn": 1961, "fiscalYear": 2024, "totalPay": 779114, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Andrea Levin Christopher", "title": "Executive Director of Corporate Communications & Investor Relations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Premchandran  Ramiya Ph.D.", "age": 63, "title": "Senior Vice President of Manufacturing & Supply Chain", "yearBorn": 1961, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 6, "boardRisk": 4, "compensationRisk": 5, "shareHolderRightsRisk": 2, "overallRisk": 3, "governanceEpochDate": 1761955200, "compensationAsOfEpochDate": 1735603200, "irWebsite": "http://www.isotechnika.com/for_investors/", "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 13.95, "open": 14.6, "dayLow": 14.51, "dayHigh": 15.27, "regularMarketPreviousClose": 13.95, "regularMarketOpen": 14.6, "regularMarketDayLow": 14.51, "regularMarketDayHigh": 15.27, "payoutRatio": 0.0, "beta": 1.457, "trailingPE": 26.089285, "forwardPE": 27.055553, "volume": 2399092, "regularMarketVolume": 2399092, "averageVolume": 1770696, "averageVolume10days": 2371290, "averageDailyVolume10Day": 2371290, "bid": 14.61, "ask": 14.68, "bidSize": 3, "askSize": 1, "marketCap": 1926190592, "fiftyTwoWeekLow": 6.55, "fiftyTwoWeekHigh": 16.2, "allTimeHigh": 33.972, "allTimeLow": 1.41, "priceToSalesTrailing12Months": 7.2465487, "fiftyDayAverage": 12.2248, "twoHundredDayAverage": 9.514725, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 1652894592, "profitMargins": 0.29283002, "floatShares": 128271635, "sharesOutstanding": 131840559, "sharesShort": 8394164, "sharesShortPriorMonth": 8982210, "sharesShortPreviousMonthDate": 1757894400, "dateShortInterest": 1760486400, "sharesPercentSharesOut": 0.0638, "heldPercentInsiders": 0.0714, "heldPercentInstitutions": 0.45269, "shortRatio": 4.89, "shortPercentOfFloat": 0.0699, "impliedSharesOutstanding": 131840559, "bookValue": 2.774, "priceToBook": 5.2667627, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "earningsQuarterlyGrowth": 1.199, "netIncomeToCommon": 77837000, "trailingEps": 0.56, "forwardEps": 0.54, "enterpriseToRevenue": 6.218, "enterpriseToEbitda": 16.438, "52WeekChange": 0.64310956, "SandP52WeekChange": 0.1198014, "quoteType": "EQUITY", "currentPrice": 14.61, "targetHighPrice": 21.0, "targetLowPrice": 11.0, "targetMeanPrice": 14.16667, "targetMedianPrice": 13.5, "recommendationMean": 1.33333, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 6, "totalCash": 351508000, "totalCashPerShare": 2.666, "ebitda": 100551000, "totalDebt": 78212000, "quickRatio": 5.018, "currentRatio": 5.756, "totalRevenue": 265808000, "debtToEquity": 21.383, "revenuePerShare": 1.941, "returnOnAssets": 0.09413999, "returnOnEquity": 0.20653, "grossProfits": 213076992, "freeCashflow": 85213872, "operatingCashflow": 120104000, "earningsGrowth": 1.3, "revenueGrowth": 0.084, "grossMargins": 0.80162, "ebitdaMargins": 0.37827998, "operatingMargins": 0.40487, "financialCurrency": "USD", "symbol": "AUPH", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "earningsTimestamp": 1762263000, "earningsTimestampStart": 1762263000, "earningsTimestampEnd": 1762263000, "earningsCallTimestampStart": 1762263000, "earningsCallTimestampEnd": 1762263000, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": 0.56, "epsForward": 0.54, "epsCurrentYear": 0.795, "priceEpsCurrentYear": 18.377357, "cryptoTradeable": false, "marketState": "CLOSED", "shortName": "Aurinia Pharmaceuticals Inc", "longName": "Aurinia Pharmaceuticals Inc.", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1409751000000, "postMarketChangePercent": 0.27378482, "postMarketPrice": 14.65, "postMarketChange": 0.03999996, "regularMarketChange": 0.66, "regularMarketDayRange": "14.51 - 15.27", "fullExchangeName": "NasdaqGM", "averageDailyVolume3Month": 1770696, "fiftyTwoWeekLowChange": 8.059999, "fiftyTwoWeekLowChangePercent": 1.2305342, "fiftyTwoWeekRange": "6.55 - 16.2", "fiftyTwoWeekHighChange": -1.5900011, "fiftyTwoWeekHighChangePercent": -0.09814821, "fiftyTwoWeekChangePercent": 64.31096, "fiftyDayAverageChange": 2.3851995, "fiftyDayAverageChangePercent": 0.19511154, "twoHundredDayAverageChange": 5.095275, "twoHundredDayAverageChangePercent": 0.5355147, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.3 - Strong Buy", "regularMarketChangePercent": 4.73118, "regularMarketPrice": 14.61, "corporateActions": [], "postMarketTime": 1762563396, "regularMarketTime": 1762549201, "exchange": "NGM", "messageBoardId": "finmb_882669", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "displayName": "Aurinia Pharmaceuticals", "trailingPegRatio": null, "__fetch_time": "2025-11-08"}]